Sarepta Therapeutics | SRPT - Assets

Stock Price
18.90
Daily Change
0.78 4.30%
Monthly
-17.11%
Yearly
-82.33%
Q1 Forecast
18.29

Sarepta Therapeutics reported $3.49B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Acadia Pharmaceuticals USD 1.33B 105.22M Sep/2025
Agios Pharmaceuticals USD 1.3B 88.48M Dec/2025
Alnylam Pharmaceuticals USD 4.97B 114.67M Dec/2025
Amgen USD 90.59B 445M Dec/2025
BioCryst Pharmaceuticals USD 446.42M 10.76M Sep/2025
Biogen USD 29.44B 232M Dec/2025
BioMarin Pharmaceutical USD 7.59B 20.85M Dec/2025
Capricor Therapeutics USD 126.44M 7.13M Sep/2025
Daiichi Sankyo JPY 3.82T 252.52B Dec/2025
Eli Lilly USD 112.48B 2.46B Dec/2025
Esperion Therapeutics USD 364.02M 16.93M Sep/2025
Gilead Sciences USD 59.02B 490M Dec/2025
Incyte USD 6.96B 627.62M Dec/2025
Insmed USD 2.26B 96.18M Dec/2025
Ionis Pharmaceuticals USD 3.03B 47.96M Sep/2025
Moderna USD 12.34B 203M Dec/2025
Nektar Therapeutics USD 301.35M 93.81M Sep/2025
Neurocrine Biosciences USD 4.63B 365.8M Dec/2025
Novavax USD 1.18B 156.66M Sep/2025
Pfizer USD 208.73B 2.64B Sep/2025
PTC Therapeutics USD 2.9B 255.07M Dec/2025
Regeneron Pharmaceuticals USD 40.56B 389.3M Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sangamo BioSciences USD 97.56M 11.39M Jun/2025
Sanofi EUR 126.81B 2.99B Dec/2025
Sarepta Therapeutics USD 3.49B 186.38M Sep/2025
Tectonic Therapeutic USD 277M 18.31M Sep/2025
Ultragenyx Pharmaceutical USD 1.53B 341.56M Dec/2025
Vertex Pharmaceuticals USD 25.64B 780.7M Dec/2025